| Net (loss) income | -14.6M |
| Depreciation | 288K |
| Deferred loan fees | 496K |
| Provision for loan losses | 18.94M |
| Stock-based compensation expense | 280K |
| Net amortization of investment securities | -547K |
| Loss (gain) on sales of securities | 441K |
| Increase in cash surrender value of bank owned life insurance | -321K |
| Loss on sale of other real estate | 498K |
| Loss on repossessions | 14.91M |
| Accrued interest receivable | -1.44M |
| Accrued interest payable | 214K |
| Income tax receivable | -7.3M |
| Other assets | 1.03M |
| Other liabilities | -1.65M |
| Net cash provided by operating activities | 11.25M |
| Purchases of securities available for sale | -121.25M |
| Proceeds from sales of securities available for sale | 72.76M |
| Proceeds from maturities, prepayments and calls on securities available for sale | 13.66M |
| Proceeds from sale of other real estate | 867K |
| Proceeds from sale of repossessions | 839K |
| Net change in loans | 55.08M |
| Net purchases of premises and equipment | -7K |
| Net cash provided by (used by) investing activities | 21.95M |
| Net change in deposits | 42.84M |
| Payments on short-term debt | -351K |
| Payments on long-term debt | 0 |
| Preferred stock dividends | -375K |
| Warrant accretion expense | 46K |
| Issuance of common stock | 10K |
| Net cash provided by (used by) financing activities | 42.17M |
| Net change in cash and cash equivalents | 75.37M |
| Cash and cash equivalents at beginning of period | 20.74M |
| Cash and cash equivalents at end of period | 96.1M |
| Cash paid during period for interest | 13.45M |
| Cash paid during period for income taxes | 12K |
| Loans foreclosed upon with repossessions | 8.12M |
| Non-cash transfer of loans to other real estate | 5.36M |
| Loans originated from the sale of repossessions | 8.24M |